ImmuPharma in licensing talks for lupus drug
Thursday, November 3, 2011
Good news! Investigational Lupuzor gets go-ahead to start a Phase III trial from U.S., European and Japanese regulatory authorities.
On the go?
Text INFO to 50555 and opt-in to receive breaking news about lupus on your mobile phone.
Message and Data Rates May Apply. Text STOP to 50555 to STOP. Text HELP to 50555 for HELP. Full Terms